Dopamine Transporter Changes in Neuropsychiatric Disorders

Advances in Pharmacology

Volumn 42, Issue C, 1997, Pages 219-223

  Wong, D F ^a   Ricaurte, G ^a   Grunder G ^e   Rothman, R ^b   Naidu, S ^a   Singer, H ^a   Harris, J ^a   Yokoi, F ^a   Villemagne, V ^a   Szymanski, S ^a   Gjedde, A ^c   Kuhad, M ^d  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^c AARHUS UNIVERSITY   (Denmark)

^d EMORY UNIVERSITY   (United States)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77949278911     PISSN: 10543589     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1054-3589(08)60732-2     Document Type: Article

References (13)

1. 11C]WIN 35,428. Synapse 15 (1993) 130-142
2. Wong D.F., Harris J.C., Naidu S., Yokoi F., Marenco S., Dannals R.F., Ravert H.T., Yaster M., Evans A., Rousset O., Bryan R.N., Gjedde A., Kuhar M.J., and Breese G.R. Dopamine transporters are markedly reduced in Lesch-Nyhan disease in vivo. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 5539-5543
3. Ernst M., Zametkin A.J., Matochik J.A., Pascualvaca D., Jons P.H., Hardy K., Hankerson J.G., Doudet D.J., and Cohen R.M. Presynaptic dopaminergic deficits in Lesch-Nyhan disease. N. Engl. J. Med. 334 (1996) 1568-1572
4. Chiron C., Bulteau C., Loc'hRaynaud C.C., Garreau B., Syrota A., and Maziere B. Dopaminergic D2 receptor SPECT imaging in Ratt syndrome: increase of specific binding in striatum. J. Nucl. Med. 34 (1993) 1717-1721
5. Singer H.S., Hahn I.H., and Moran T.H. Abnormal dopamine uptake sites in postmortem striatum from patients with Tourette's syndrome. Ann. Neurol. 30 (1991) 558-562
6. Malison R.T., McDougle C.I., van Dyck C.H., Scahill L., Baldwin R.M., Seibyl J.P., Price L.H., Leckman J.F., and Innis R.B. [123I]beta-CIT SPECT imaging of striatal doparnine transporter binding in Tourette's disorder. Am. J. Psychiatry 152 (1995) 1359-1361
7. 11C]WIN 35,428 PET imaging are elevated in Tourette syndrome. J. Nucl. Med. 35 (1994) 130P (Abstract)
8. Turjanski N., Sawle G.V., Playford E.D., Weeks R., Lammertsma A.A., Lees A.J., and Brooks D.J. PET studies of the presynaptic and postsynaptic dopaminergic system in Tourette's syndrome. J. Neurol. Neurosurg. Psychiatry 57 (1994) 688-692
9. Singer H.S., Wong D.F., Brown J.E., Brandt J., Krafft L., Shaya E., Dannals R.F., and Wagner Jr. H.N. Positron emission tomography evaluation of dopamine D-2 receptors in adults with Tourette syndrome. Adv. Neurol. 58 (1992) 233-239
10. George M.S., Robertson M.M., Costa D.C., Ell P.J., Trimble M.R., Pilowsky L., and Verhoeff N.P. Dopamine receptor availability in Tourette's syndrome. Psychiatry Res. 55 (1994) 193-203
11. Volkow N.D., Wang G.J., Fischman M.W., Foltin R.W., Fowler J.S., Abumrad N.N., Vitkun S., Logan J., Gatley S.J., Pappas N., Hitzemann R., and Shea C.E. Relationship between subjective effects of cocaine and dopamine transporter occupancy. Nature 386 (1997) 827-830
12. Seiden, L. S., Ricaurte, G. A. Neurotoxicity of methamphetamine and related drugs. In Psychopharmacology-A Generation of Progress. (Meltzer, H. Y., ed.), pp. 359-366. Raven Press, New York, NY.
13. Ricaurte G., Wong D.F., Szaho Z., Yokoi F., Scheffel U., Matthews W., Ravert M., Dannals R., and Naidu S. Reductions in brain dopamine and serotonin transporters detected in humans previously exposed to repeated high doses of methcathinone using PET. Soc. Neurosci. 22 (1996) 1915 (Ahstract)